Skip to main contentSkip to main content
info@smcsalud.org
Educational Guide

Alzheimer's Evaluation Options

An educational guide for families and caregivers exploring Alzheimer's evaluation options — comprehensive neuroimaging, neuropsychological testing, and specialist consultation. Information to support informed decisions, in consultation with your healthcare provider.

Cuban biotech innovation Cognitive rehabilitation For US families & caregivers
7.4M
Americans 65+ with Alzheimer's (2026)
13M
Projected by 2050 (Alzheimer's Assn.)
$409B
Annual US dementia care cost (2026)
4–8 wks
Cuba program cycles (individualized)

Educational Resource — Not Medical Advice

The information on this page is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your qualified healthcare provider before making decisions about treatment options.

We do not target, identify, or retarget individuals based on health conditions. This content is intended for families and caregivers seeking information about international treatment options, and is discoverable through organic search.

Understanding Evaluation

What Is an

An Alzheimer's evaluation is a comprehensive assessment that combines neuroimaging, cognitive testing, medical history, and specialist consultation to diagnose and stage the disease. Early and accurate evaluation helps families explore all available options.

Neuroimaging

MRI and CT scans to visualize brain structure, rule out other causes, and detect patterns consistent with Alzheimer's disease.

Neuropsychological Testing

Standardized cognitive assessments (MMSE, MoCA) measuring memory, attention, language, and executive function.

Medical History

Detailed review of symptoms, progression timeline, family history, medications, and contributing conditions.

Specialist Consultation

Neurologist consultation to integrate all findings, confirm diagnosis, stage the disease, and discuss treatment options.

Biomarker Testing

Where available, cerebrospinal fluid analysis or PET imaging for amyloid and tau pathology.

Family Conference

A meeting with the family to explain findings, answer questions, and discuss the path forward.

Why Early Evaluation Matters

The Value of

The Alzheimer's Association notes that early and accurate diagnosis can help patients explore treatment options, maintain independence longer, and consider clinical trials. Cuba's evaluation program provides a comprehensive, independent assessment.

Explore Options

Early evaluation opens the door to all available treatment options, including international programs like Cuba's.

Maintain Independence

Early intervention may help preserve cognitive function and daily independence for longer.

Plan Ahead

An accurate diagnosis allows families to plan for future care, legal, and financial needs.

Independent Perspective

Cuba's evaluation provides an independent, international specialist perspective on your diagnosis and treatment options.

Cuban Biotechnology

NeuralCIM® — Advanced Therapy for Alzheimer's Disease

Supporting memory, preserving identity, restoring quality of life.

Cuban biotechnology, now within reach for patients from around the world. Speak with our coordinators about NeuralCIM Alzheimer's care in Cuba.

Cuba's Approach

The Cuban Neuro-Care Program

Cuba has built a neuro-care program that combines its own biotechnology — NeuralCIM, a low-sialic-acid erythropoietin developed by the Center for Molecular Immunology — with intensive, multidisciplinary rehabilitation. This approach is not available in the United States.

  • NeuralCIM neuroprotective therapy — a Cuban biotechnology innovation
  • Intensive cognitive rehabilitation delivered by neuropsychologists
  • Multidisciplinary team: neurologists, therapists, and specialized nursing
  • 4–8 week individualized program cycles with continuous monitoring
  • Coordinated aftercare and handover to your US physician
  • English-speaking coordinators at every step

NeuralCIM®

Cuban biotechnology

Low-sialic-acid erythropoietin developed by Cuba's Center for Molecular Immunology (CIM), applied in neuro-care for its neurotrophic and neuroprotective properties.

4–8 Week Cycles

Multidisciplinary Team

Your Journey to Cuba

From First Inquiry to Safe Return Home

01

Contact Us

Share your medical information and history through our inquiry form or coordinators.

02

Free Evaluation

Our neurology experts review your US records and design a personalized treatment plan.

03

Travel Coordination

We assist with e-Visa, flights, and comfortable accommodation in Cuba for patient and family.

04

Treatment

Receive personalized neuro-care with continuous, multidisciplinary support.

05

Aftercare

Coordinated handover to your US physician with a long-term monitoring plan.

Frequently Asked Questions

Your Questions Answered

Request a Free Clinical Evaluation

Share your medical information with our neuro-care team and receive a personalized evaluation — often within 24–48 hours. No obligation, no travel required to get started.